Report Detail

Pharma & Healthcare Global Sodium Iodide (131I) for Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4612907
  • |
  • 02 September, 2024
  • |
  • Global
  • |
  • 89 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Sodium Iodide (131I) is a radiopharmaceutical containing the beta- and gamma-emitting radioisotope I-131. After absorption, the iodide is distributed through the extracellular fluid of the body and accumulates in the thyroid gland, thereby allowing the imaging of the thyroid.
According to our (Global Info Research) latest study, the global Sodium Iodide (131I) for Therapy market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
In terms of product type, Capsule is the largest segment, with a share over 60%.
This report is a detailed and comprehensive analysis for global Sodium Iodide (131I) for Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Sodium Iodide (131I) for Therapy market size and forecasts, in consumption value ($ Million), 2019-2030
Global Sodium Iodide (131I) for Therapy market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Sodium Iodide (131I) for Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Sodium Iodide (131I) for Therapy market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sodium Iodide (131I) for Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sodium Iodide (131I) for Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Curium Pharma, HTA Co., Ltd., Jubilant Pharmova, PDRadiopharma Inc., Yantai Dongcheng Pharmaceutical Group Co, NTP Radioisotopes, International Isotopes Inc, ANSTO, POLATOM(NCBJ), Isotope JSC (Rosatom), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Sodium Iodide (131I) for Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Sodium Iodide (131I) for Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Capsule
Solution
Market segment by Application
Hyperthyroidism Treatment
Thyroid Cancer Treatment
Market segment by players, this report covers
Curium Pharma
HTA Co., Ltd.
Jubilant Pharmova
PDRadiopharma Inc.
Yantai Dongcheng Pharmaceutical Group Co
NTP Radioisotopes
International Isotopes Inc
ANSTO
POLATOM(NCBJ)
Isotope JSC (Rosatom)
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Sodium Iodide (131I) for Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Sodium Iodide (131I) for Therapy, with revenue, gross margin, and global market share of Sodium Iodide (131I) for Therapy from 2019 to 2024.
Chapter 3, the Sodium Iodide (131I) for Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Sodium Iodide (131I) for Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sodium Iodide (131I) for Therapy.
Chapter 13, to describe Sodium Iodide (131I) for Therapy research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Sodium Iodide (131I) for Therapy by Type
    • 1.3.1 Overview: Global Sodium Iodide (131I) for Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Sodium Iodide (131I) for Therapy Consumption Value Market Share by Type in 2023
    • 1.3.3 Capsule
    • 1.3.4 Solution
  • 1.4 Global Sodium Iodide (131I) for Therapy Market by Application
    • 1.4.1 Overview: Global Sodium Iodide (131I) for Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hyperthyroidism Treatment
    • 1.4.3 Thyroid Cancer Treatment
  • 1.5 Global Sodium Iodide (131I) for Therapy Market Size & Forecast
  • 1.6 Global Sodium Iodide (131I) for Therapy Market Size and Forecast by Region
    • 1.6.1 Global Sodium Iodide (131I) for Therapy Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Sodium Iodide (131I) for Therapy Market Size by Region, (2019-2030)
    • 1.6.3 North America Sodium Iodide (131I) for Therapy Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Sodium Iodide (131I) for Therapy Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Sodium Iodide (131I) for Therapy Market Size and Prospect (2019-2030)
    • 1.6.6 South America Sodium Iodide (131I) for Therapy Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Sodium Iodide (131I) for Therapy Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Curium Pharma
    • 2.1.1 Curium Pharma Details
    • 2.1.2 Curium Pharma Major Business
    • 2.1.3 Curium Pharma Sodium Iodide (131I) for Therapy Product and Solutions
    • 2.1.4 Curium Pharma Sodium Iodide (131I) for Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Curium Pharma Recent Developments and Future Plans
  • 2.2 HTA Co., Ltd.
    • 2.2.1 HTA Co., Ltd. Details
    • 2.2.2 HTA Co., Ltd. Major Business
    • 2.2.3 HTA Co., Ltd. Sodium Iodide (131I) for Therapy Product and Solutions
    • 2.2.4 HTA Co., Ltd. Sodium Iodide (131I) for Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 HTA Co., Ltd. Recent Developments and Future Plans
  • 2.3 Jubilant Pharmova
    • 2.3.1 Jubilant Pharmova Details
    • 2.3.2 Jubilant Pharmova Major Business
    • 2.3.3 Jubilant Pharmova Sodium Iodide (131I) for Therapy Product and Solutions
    • 2.3.4 Jubilant Pharmova Sodium Iodide (131I) for Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Jubilant Pharmova Recent Developments and Future Plans
  • 2.4 PDRadiopharma Inc.
    • 2.4.1 PDRadiopharma Inc. Details
    • 2.4.2 PDRadiopharma Inc. Major Business
    • 2.4.3 PDRadiopharma Inc. Sodium Iodide (131I) for Therapy Product and Solutions
    • 2.4.4 PDRadiopharma Inc. Sodium Iodide (131I) for Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 PDRadiopharma Inc. Recent Developments and Future Plans
  • 2.5 Yantai Dongcheng Pharmaceutical Group Co
    • 2.5.1 Yantai Dongcheng Pharmaceutical Group Co Details
    • 2.5.2 Yantai Dongcheng Pharmaceutical Group Co Major Business
    • 2.5.3 Yantai Dongcheng Pharmaceutical Group Co Sodium Iodide (131I) for Therapy Product and Solutions
    • 2.5.4 Yantai Dongcheng Pharmaceutical Group Co Sodium Iodide (131I) for Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Yantai Dongcheng Pharmaceutical Group Co Recent Developments and Future Plans
  • 2.6 NTP Radioisotopes
    • 2.6.1 NTP Radioisotopes Details
    • 2.6.2 NTP Radioisotopes Major Business
    • 2.6.3 NTP Radioisotopes Sodium Iodide (131I) for Therapy Product and Solutions
    • 2.6.4 NTP Radioisotopes Sodium Iodide (131I) for Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 NTP Radioisotopes Recent Developments and Future Plans
  • 2.7 International Isotopes Inc
    • 2.7.1 International Isotopes Inc Details
    • 2.7.2 International Isotopes Inc Major Business
    • 2.7.3 International Isotopes Inc Sodium Iodide (131I) for Therapy Product and Solutions
    • 2.7.4 International Isotopes Inc Sodium Iodide (131I) for Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 International Isotopes Inc Recent Developments and Future Plans
  • 2.8 ANSTO
    • 2.8.1 ANSTO Details
    • 2.8.2 ANSTO Major Business
    • 2.8.3 ANSTO Sodium Iodide (131I) for Therapy Product and Solutions
    • 2.8.4 ANSTO Sodium Iodide (131I) for Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 ANSTO Recent Developments and Future Plans
  • 2.9 POLATOM(NCBJ)
    • 2.9.1 POLATOM(NCBJ) Details
    • 2.9.2 POLATOM(NCBJ) Major Business
    • 2.9.3 POLATOM(NCBJ) Sodium Iodide (131I) for Therapy Product and Solutions
    • 2.9.4 POLATOM(NCBJ) Sodium Iodide (131I) for Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 POLATOM(NCBJ) Recent Developments and Future Plans
  • 2.10 Isotope JSC (Rosatom)
    • 2.10.1 Isotope JSC (Rosatom) Details
    • 2.10.2 Isotope JSC (Rosatom) Major Business
    • 2.10.3 Isotope JSC (Rosatom) Sodium Iodide (131I) for Therapy Product and Solutions
    • 2.10.4 Isotope JSC (Rosatom) Sodium Iodide (131I) for Therapy Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Isotope JSC (Rosatom) Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Sodium Iodide (131I) for Therapy Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Sodium Iodide (131I) for Therapy by Company Revenue
    • 3.2.2 Top 3 Sodium Iodide (131I) for Therapy Players Market Share in 2023
    • 3.2.3 Top 6 Sodium Iodide (131I) for Therapy Players Market Share in 2023
  • 3.3 Sodium Iodide (131I) for Therapy Market: Overall Company Footprint Analysis
    • 3.3.1 Sodium Iodide (131I) for Therapy Market: Region Footprint
    • 3.3.2 Sodium Iodide (131I) for Therapy Market: Company Product Type Footprint
    • 3.3.3 Sodium Iodide (131I) for Therapy Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Sodium Iodide (131I) for Therapy Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Sodium Iodide (131I) for Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Sodium Iodide (131I) for Therapy Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Sodium Iodide (131I) for Therapy Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Sodium Iodide (131I) for Therapy Consumption Value by Type (2019-2030)
  • 6.2 North America Sodium Iodide (131I) for Therapy Market Size by Application (2019-2030)
  • 6.3 North America Sodium Iodide (131I) for Therapy Market Size by Country
    • 6.3.1 North America Sodium Iodide (131I) for Therapy Consumption Value by Country (2019-2030)
    • 6.3.2 United States Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Sodium Iodide (131I) for Therapy Consumption Value by Type (2019-2030)
  • 7.2 Europe Sodium Iodide (131I) for Therapy Consumption Value by Application (2019-2030)
  • 7.3 Europe Sodium Iodide (131I) for Therapy Market Size by Country
    • 7.3.1 Europe Sodium Iodide (131I) for Therapy Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 7.3.3 France Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Sodium Iodide (131I) for Therapy Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Sodium Iodide (131I) for Therapy Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Sodium Iodide (131I) for Therapy Market Size by Region
    • 8.3.1 Asia-Pacific Sodium Iodide (131I) for Therapy Consumption Value by Region (2019-2030)
    • 8.3.2 China Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 8.3.5 India Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Sodium Iodide (131I) for Therapy Consumption Value by Type (2019-2030)
  • 9.2 South America Sodium Iodide (131I) for Therapy Consumption Value by Application (2019-2030)
  • 9.3 South America Sodium Iodide (131I) for Therapy Market Size by Country
    • 9.3.1 South America Sodium Iodide (131I) for Therapy Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Sodium Iodide (131I) for Therapy Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Sodium Iodide (131I) for Therapy Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Sodium Iodide (131I) for Therapy Market Size by Country
    • 10.3.1 Middle East & Africa Sodium Iodide (131I) for Therapy Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Sodium Iodide (131I) for Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Sodium Iodide (131I) for Therapy Market Drivers
  • 11.2 Sodium Iodide (131I) for Therapy Market Restraints
  • 11.3 Sodium Iodide (131I) for Therapy Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Sodium Iodide (131I) for Therapy Industry Chain
  • 12.2 Sodium Iodide (131I) for Therapy Upstream Analysis
  • 12.3 Sodium Iodide (131I) for Therapy Midstream Analysis
  • 12.4 Sodium Iodide (131I) for Therapy Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Sodium Iodide (131I) for Therapy. Industry analysis & Market Report on Sodium Iodide (131I) for Therapy is a syndicated market report, published as Global Sodium Iodide (131I) for Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Sodium Iodide (131I) for Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,634.36
    3,951.54
    5,268.72
    3,132.00
    4,698.00
    6,264.00
    494,682.00
    742,023.00
    989,364.00
    291,380.40
    437,070.60
    582,760.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report